Samuel R. Denmeade

Also affiliated with Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore

MedicineNursingBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 24 papers. Top paper: “Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial”.

Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02284-w

N/A

3.0DataRank · unranked

106 citations

Angelo M. De Marzo, Tamara L. Lotan, Hao Wang, Sin Chan, Su Jin Lim +19 more

Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial

Nature Communications(2024)10.1038/s41467-023-44514-2

N/A

1.3DataRank · unranked

49 citations

Mary‐Ellen Taplin, Rahul Aggarwal, Laura A. Sena, Hao Wang, Hanfei Qi +15 more

Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.043

N/A

1.2DataRank · unranked

47 citations

Hao Wang, Su J. Lim ScM, Irina Rifkind, Nduku Ngomba, John T. Isaacs +10 more

Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors

Oncogene(2020)10.1038/s41388-020-01479-6

N/A

0.701DataRank · unranked

106 citations

Susan L. Dalrymple, Ilsa M. Coleman, Shun Zheng, Jianfeng Xu, Jody E. Hooper +10 more

High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0225

N/A

0.554DataRank · unranked

18 citations

Marianna Zahurak, Adel Mandl, Nicole A. Metri, Aliya Lalji, Elisabeth I. Heath +18 more

Targeted delivery of cytotoxic proteins to prostate cancer via conjugation to small molecule urea-based PSMA inhibitors

Scientific Reports(2021)10.1038/s41598-021-94534-5

N/A

0.434DataRank · unranked

17 citations

David Rosen, Linto Antony, H. M. Harper, Deepankar Das, Xing Yang +5 more

From Plant to Patient: Thapsigargin, a Tool for Understanding Natural Product Chemistry, Total Syntheses, Biosynthesis, Taxonomy, ATPases, Cell Death, and Drug Development

Progress in the Chemistry of Organic Natural Products(2021)10.1007/978-3-030-64853-4_2

N/A

0.345DataRank · unranked

9 citations

Henrik Toft Simonsen, Nikolai Engedal, Poul Nissen, Jesper Vuust Møller, Samuel R. Denmeade +2 more

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00798-z

N/A

0.345DataRank · unranked

9 citations

Russell K. Pachynski, Samuel R. Denmeade, Rahul Aggarwal, Jiehui Deng, Victor Adorno Febles +27 more

Liver Fibrosis Scores and Prostate Cancer Risk and Mortality in the Atherosclerosis Risk in Communities Study

Cancer Prevention Research(2023)10.1158/1940-6207.capr-23-0168

N/A

0.280DataRank · unranked

3 citations

Mariana Lazo, Jiayun Lu, David Couper, Anna E. Prizment, Mara Z. Vitolins +4 more

Third generation quinoline‐3‐carboxamide transcriptional disrupter of HDAC4, HIF‐1α, and MEF‐2 signaling for metastatic castration‐resistant prostate cancer

The Prostate(2023)10.1002/pros.24606

N/A

0.269DataRank · unranked

5 citations

Susan L. Dalrymple, Lizamma Antony, David M. Rosen, Ilsa M. Coleman, Peter S. Nelson +7 more

Phase 2 study of olaparib (without ADT) in men with biochemically recurrent prostate cancer (BCR) after prostatectomy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5087

N/A

0.241DataRank · unranked

4 citations

Benjamin A. Teply, Su Jin Lim, Hao Wang, Shifeng Mao, William Kevin Kelly +10 more

Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer

medRxiv(2024)10.1101/2024.12.12.24318845

N/A

0.208DataRank · unranked

3 citations

Sheila Jonnatan, David E. Sanin, Varsha Vakkala, Anoushka Kadam, Shivani Kumar +20 more

RESTORE: A single-arm, open-label phase II trial of bipolar androgen therapy (BAT) in men with metastatic castration resistant prostate cancer (mCRPC)—A comparison of post-abiraterone (Abi) versus post-enzalutamide (Enza) patients (Pts).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5576

N/A

0.104DataRank · unranked

1 citations

Hao Wang, Michael T. Schweizer, Michael A. Carducci, Channing J. Paller, Benjamin A. Teply +5 more

Microparticle Encapsulation of a Prostate-targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-resistant Prostate Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0227

N/A

0DataRank · unranked

3 citations

Lizamma Antony, Oren Levy, Nitin Joshi, Brian W. Simons, Susan L. Dalrymple +12 more

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer

The Prostate(2024)10.1002/pros.24712

N/A

0DataRank · unranked

17 citations

Lukasz P. Gondek, В. Даниэльс, Changxue Lu, Sergiu Paşca, Jiajun Xie +7 more

Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models

The Prostate(2024)10.1002/pros.24707

N/A

0DataRank · unranked

12 citations

Adel Mandl, Timothy Krueger, Susan L. Dalrymple, Lizamma Antony, Jennifer Dias +16 more

Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer

The Prostate(2020)10.1002/pros.23955

N/A

0DataRank · unranked

37 citations

Eugene Shenderov, Mario A. Eisenberger, Sushant K. Kachhap, Drew M. Pardoll, Samuel R. Denmeade +2 more

Nectin‐4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical Study

The Prostate(2025)10.1002/pros.24846

N/A

0DataRank · unranked

3 citations

Evangelia Vlachou, Sunil Patel, Max Kates, Burles A. Johnson, Armine K. Smith +9 more

Bipolar androgen therapy (BAT): A patient's guide

The Prostate(2022)10.1002/pros.24328

N/A

0DataRank · unranked

27 citations

Emmanuel S. Antonarakis, Mark C. Markowski, Samuel R. Denmeade

Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer

Cancer Research(2021)10.1158/0008-5472.can-20-3607

N/A

0DataRank · unranked

48 citations

Janet Mendonca, Olutosin Owoyemi, Kavya Boyapati, Naiju Thomas, Suthicha Kanacharoen +20 more

Prostate cancer androgen receptor activity dictates efficacy of Bipolar Androgen Therapy

medRxiv(2022)10.1101/2022.04.26.22274275

N/A

0DataRank · unranked

4 citations

Rajendra Kumar, David E. Sanin, Elizabeth A. Thompson, Dina Rosen, Susan L. Dalrymple +20 more

Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?

Cancer Research(2021)10.1158/0008-5472.can-21-1392

N/A

0DataRank · unranked

70 citations

Samuel R. Denmeade, Laura A. Sena

Data from Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer

(2023)10.1158/0008-5472.c.6513589.v1

N/A

0DataRank · unranked

0 citations

Janet Mendonca, Olutosin Owoyemi, Kavya Boyapati, Naiju Thomas, Suthicha Kanacharoen +20 more

1833P Concurrent high-dose IV Vitamin C (IVC) and docetaxel for metastatic castrate-resistant prostate cancer (mCRPC): A randomized, placebo-controlled, double-blind phase II trial

Annals of Oncology(2023)10.1016/j.annonc.2023.09.2781

N/A

0DataRank · unranked

0 citations

M.L. Zahurek, Adel Mandl, Michelle A. Rudek, Elisabeth I. Heath, Catherine H. Marshall +13 more